A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT05119569 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05119569
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-03-29
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.